Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ubiquitin-Protein Ligases | 23 | 2023 | 1841 | 2.750 |
Why?
|
Thalidomide | 10 | 2022 | 892 | 1.910 |
Why?
|
Peptide Hydrolases | 7 | 2018 | 618 | 1.580 |
Why?
|
Ikaros Transcription Factor | 7 | 2022 | 221 | 1.170 |
Why?
|
Small Molecule Libraries | 8 | 2021 | 723 | 1.160 |
Why?
|
Ubiquitination | 15 | 2023 | 990 | 0.920 |
Why?
|
Transcription Factors | 12 | 2022 | 11955 | 0.880 |
Why?
|
Adaptor Proteins, Signal Transducing | 13 | 2022 | 2973 | 0.760 |
Why?
|
Substrate Specificity | 8 | 2023 | 1828 | 0.750 |
Why?
|
Caspases | 1 | 2023 | 948 | 0.730 |
Why?
|
Proteomics | 7 | 2021 | 3256 | 0.660 |
Why?
|
Drug Design | 4 | 2021 | 1099 | 0.650 |
Why?
|
Duane Retraction Syndrome | 1 | 2018 | 61 | 0.650 |
Why?
|
Drug Discovery | 3 | 2021 | 1055 | 0.650 |
Why?
|
Protein Kinase Inhibitors | 11 | 2021 | 5406 | 0.620 |
Why?
|
Acetamides | 1 | 2018 | 250 | 0.590 |
Why?
|
Histone Deacetylases | 1 | 2021 | 750 | 0.580 |
Why?
|
Structure-Activity Relationship | 7 | 2022 | 3200 | 0.580 |
Why?
|
Cryoelectron Microscopy | 5 | 2023 | 515 | 0.570 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2023 | 2976 | 0.560 |
Why?
|
Carrier Proteins | 5 | 2023 | 5098 | 0.560 |
Why?
|
Cell Cycle Proteins | 4 | 2021 | 3483 | 0.540 |
Why?
|
Proteome | 3 | 2022 | 1762 | 0.530 |
Why?
|
Polymers | 1 | 2022 | 1613 | 0.520 |
Why?
|
Immunologic Factors | 2 | 2022 | 1568 | 0.510 |
Why?
|
Proteins | 3 | 2021 | 6080 | 0.480 |
Why?
|
Thiophenes | 1 | 2018 | 600 | 0.480 |
Why?
|
Crystallography, X-Ray | 10 | 2021 | 1982 | 0.480 |
Why?
|
Sulfonamides | 2 | 2020 | 1923 | 0.480 |
Why?
|
Protein Kinases | 1 | 2020 | 1664 | 0.470 |
Why?
|
Models, Molecular | 10 | 2021 | 5465 | 0.460 |
Why?
|
Peptide Termination Factors | 2 | 2022 | 58 | 0.420 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2881 | 0.420 |
Why?
|
Indoles | 1 | 2019 | 1842 | 0.410 |
Why?
|
Molecular Structure | 5 | 2021 | 1944 | 0.400 |
Why?
|
Polymerization | 2 | 2022 | 162 | 0.400 |
Why?
|
Biocatalysis | 3 | 2023 | 178 | 0.380 |
Why?
|
DNA-Binding Proteins | 7 | 2021 | 9741 | 0.380 |
Why?
|
Protein Binding | 11 | 2020 | 9559 | 0.370 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2021 | 286 | 0.370 |
Why?
|
Casein Kinase Ialpha | 2 | 2021 | 25 | 0.370 |
Why?
|
Methyltransferases | 2 | 2023 | 353 | 0.360 |
Why?
|
Cell Line, Tumor | 23 | 2021 | 16729 | 0.340 |
Why?
|
Ligands | 7 | 2022 | 3286 | 0.340 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5939 | 0.330 |
Why?
|
HEK293 Cells | 5 | 2021 | 4267 | 0.320 |
Why?
|
Cell Line | 6 | 2021 | 16574 | 0.320 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 3043 | 0.320 |
Why?
|
Kinetics | 5 | 2021 | 6654 | 0.300 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2019 | 330 | 0.290 |
Why?
|
Antibodies, Viral | 3 | 2022 | 2992 | 0.290 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 966 | 0.280 |
Why?
|
Multiple Myeloma | 5 | 2022 | 4964 | 0.280 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1162 | 0.280 |
Why?
|
Antineoplastic Agents | 9 | 2021 | 13620 | 0.280 |
Why?
|
Ubiquitin | 2 | 2021 | 827 | 0.260 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2022 | 5191 | 0.250 |
Why?
|
RNA, Transfer | 2 | 2023 | 308 | 0.240 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2022 | 23 | 0.230 |
Why?
|
Humans | 61 | 2023 | 715636 | 0.230 |
Why?
|
Piperazines | 4 | 2021 | 2527 | 0.230 |
Why?
|
Binding Sites | 7 | 2021 | 6212 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2022 | 68 | 0.220 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2023 | 437 | 0.220 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 30 | 0.220 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2021 | 50 | 0.220 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2023 | 216 | 0.220 |
Why?
|
tRNA Methyltransferases | 1 | 2021 | 51 | 0.210 |
Why?
|
Cyclin-Dependent Kinase 9 | 2 | 2021 | 71 | 0.210 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4490 | 0.210 |
Why?
|
Chimera | 1 | 2022 | 476 | 0.210 |
Why?
|
DNA Damage | 5 | 2019 | 2432 | 0.210 |
Why?
|
Methanol | 1 | 2021 | 90 | 0.210 |
Why?
|
Neoplasms | 4 | 2022 | 20514 | 0.210 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2021 | 102 | 0.200 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2021 | 234 | 0.200 |
Why?
|
Indoleacetic Acids | 1 | 2020 | 47 | 0.200 |
Why?
|
Molecular Conformation | 2 | 2019 | 550 | 0.200 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2021 | 107 | 0.200 |
Why?
|
Eukaryota | 1 | 2021 | 103 | 0.200 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2020 | 1311 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 201 | 0.190 |
Why?
|
Pyridines | 3 | 2021 | 2843 | 0.190 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2021 | 269 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2020 | 187 | 0.190 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 194 | 0.190 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 206 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2020 | 111 | 0.190 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 258 | 0.190 |
Why?
|
Spodoptera | 1 | 2019 | 156 | 0.190 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 336 | 0.190 |
Why?
|
Lymphoma, T-Cell | 1 | 2022 | 298 | 0.180 |
Why?
|
Oncogene Proteins | 2 | 2021 | 756 | 0.180 |
Why?
|
Jurkat Cells | 1 | 2021 | 778 | 0.180 |
Why?
|
HCT116 Cells | 2 | 2017 | 407 | 0.180 |
Why?
|
Cross Reactions | 1 | 2021 | 876 | 0.180 |
Why?
|
Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2019 | 520 | 0.170 |
Why?
|
Upper Extremity Deformities, Congenital | 1 | 2018 | 30 | 0.170 |
Why?
|
Databases, Protein | 1 | 2020 | 374 | 0.170 |
Why?
|
Protein Phosphatase 2 | 1 | 2020 | 224 | 0.170 |
Why?
|
Cell Proliferation | 8 | 2022 | 10603 | 0.170 |
Why?
|
GTP-Binding Proteins | 1 | 2023 | 971 | 0.170 |
Why?
|
Lysine | 1 | 2022 | 1029 | 0.170 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 512 | 0.170 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2019 | 342 | 0.160 |
Why?
|
Teratogens | 1 | 2018 | 116 | 0.160 |
Why?
|
Immunologic Surveillance | 1 | 2018 | 95 | 0.160 |
Why?
|
Cyclins | 1 | 2020 | 598 | 0.160 |
Why?
|
Viral Nonstructural Proteins | 1 | 2019 | 241 | 0.160 |
Why?
|
Mammals | 1 | 2022 | 934 | 0.160 |
Why?
|
Xenopus | 1 | 2019 | 765 | 0.160 |
Why?
|
Cullin Proteins | 3 | 2016 | 184 | 0.160 |
Why?
|
Pyrimidinones | 1 | 2019 | 373 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2021 | 580 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 11194 | 0.150 |
Why?
|
Species Specificity | 2 | 2018 | 2593 | 0.150 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2018 | 209 | 0.150 |
Why?
|
Purines | 1 | 2020 | 592 | 0.150 |
Why?
|
Frontotemporal Dementia | 1 | 2019 | 209 | 0.150 |
Why?
|
Nucleotidyltransferases | 1 | 2018 | 206 | 0.150 |
Why?
|
Biphenyl Compounds | 1 | 2021 | 884 | 0.150 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 985 | 0.150 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1222 | 0.150 |
Why?
|
Isoenzymes | 1 | 2021 | 1800 | 0.140 |
Why?
|
Tubulin | 1 | 2020 | 759 | 0.140 |
Why?
|
Acrylamides | 1 | 2017 | 233 | 0.140 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 790 | 0.140 |
Why?
|
Tauopathies | 1 | 2019 | 283 | 0.140 |
Why?
|
Catalytic Domain | 4 | 2023 | 714 | 0.140 |
Why?
|
Protein Interaction Mapping | 1 | 2019 | 643 | 0.140 |
Why?
|
Animals | 13 | 2023 | 169277 | 0.140 |
Why?
|
Protease Inhibitors | 1 | 2019 | 785 | 0.140 |
Why?
|
Lysosomes | 1 | 2020 | 893 | 0.140 |
Why?
|
Pyrazines | 1 | 2021 | 1246 | 0.140 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2018 | 487 | 0.130 |
Why?
|
Zinc Fingers | 1 | 2017 | 595 | 0.130 |
Why?
|
Phosphorylation | 6 | 2023 | 8654 | 0.130 |
Why?
|
Principal Component Analysis | 1 | 2017 | 968 | 0.130 |
Why?
|
Quinazolines | 2 | 2021 | 1407 | 0.130 |
Why?
|
Cell Survival | 3 | 2021 | 6032 | 0.130 |
Why?
|
Drug Resistance, Viral | 1 | 2019 | 798 | 0.130 |
Why?
|
Leukemia | 1 | 2022 | 1513 | 0.130 |
Why?
|
Apoptosis | 5 | 2023 | 9962 | 0.130 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 483 | 0.120 |
Why?
|
Benzamides | 1 | 2019 | 1390 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1205 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2021 | 1425 | 0.120 |
Why?
|
Pyrimidines | 3 | 2019 | 2929 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1593 | 0.120 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1005 | 0.110 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2011 | 14 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 509 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1632 | 0.110 |
Why?
|
Pyrazoles | 2 | 2019 | 1957 | 0.110 |
Why?
|
Neuroprotective Agents | 1 | 2019 | 993 | 0.110 |
Why?
|
Mice | 9 | 2022 | 80320 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2016 | 572 | 0.110 |
Why?
|
Hormones | 1 | 2016 | 852 | 0.110 |
Why?
|
ras Proteins | 1 | 2017 | 1101 | 0.110 |
Why?
|
Abnormalities, Multiple | 1 | 2018 | 1379 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2552 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1885 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2018 | 1373 | 0.100 |
Why?
|
Ultraviolet Rays | 2 | 2015 | 1066 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2461 | 0.090 |
Why?
|
Protein Stability | 2 | 2022 | 567 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2022 | 3372 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2222 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2022 | 3291 | 0.090 |
Why?
|
tau Proteins | 1 | 2019 | 1650 | 0.090 |
Why?
|
Mutation | 4 | 2022 | 29270 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2020 | 3895 | 0.090 |
Why?
|
Enzyme Activation | 2 | 2014 | 3818 | 0.090 |
Why?
|
Gene Deletion | 1 | 2017 | 2821 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2578 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2021 | 13205 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4561 | 0.080 |
Why?
|
Ubiquitins | 2 | 2022 | 370 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1252 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2019 | 2807 | 0.080 |
Why?
|
Allosteric Regulation | 2 | 2020 | 406 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2016 | 2993 | 0.080 |
Why?
|
Signal Transduction | 5 | 2021 | 23721 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 14171 | 0.070 |
Why?
|
Pandemics | 2 | 2022 | 7306 | 0.070 |
Why?
|
Protein Structure, Tertiary | 3 | 2018 | 3964 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 2446 | 0.060 |
Why?
|
DNA | 1 | 2018 | 7088 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2018 | 1778 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2020 | 19905 | 0.060 |
Why?
|
Allosteric Site | 1 | 2022 | 104 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4272 | 0.060 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 24 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2022 | 260 | 0.050 |
Why?
|
Protein Conformation | 2 | 2022 | 4039 | 0.050 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 188 | 0.050 |
Why?
|
Guanosine | 1 | 2021 | 60 | 0.050 |
Why?
|
Interleukin-3 | 1 | 2022 | 440 | 0.050 |
Why?
|
Genes, Overlapping | 1 | 2021 | 37 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6480 | 0.050 |
Why?
|
DNA Repair | 1 | 2011 | 2033 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2021 | 102 | 0.050 |
Why?
|
Chromatin | 2 | 2022 | 2683 | 0.050 |
Why?
|
Erythroid Cells | 1 | 2022 | 250 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16308 | 0.050 |
Why?
|
Phenothiazines | 1 | 2020 | 65 | 0.050 |
Why?
|
Hydrogen Bonding | 1 | 2020 | 295 | 0.050 |
Why?
|
Enzyme Activators | 1 | 2020 | 65 | 0.050 |
Why?
|
Trans-Activators | 2 | 2021 | 3051 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 127 | 0.050 |
Why?
|
Dipeptides | 1 | 2022 | 408 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19528 | 0.050 |
Why?
|
Young Adult | 3 | 2021 | 56137 | 0.050 |
Why?
|
Benzylamines | 1 | 2021 | 224 | 0.050 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 295 | 0.050 |
Why?
|
Imides | 1 | 2019 | 14 | 0.050 |
Why?
|
Solvents | 1 | 2020 | 294 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2021 | 6806 | 0.050 |
Why?
|
Phthalimides | 1 | 2018 | 15 | 0.050 |
Why?
|
Neurons | 1 | 2019 | 9377 | 0.050 |
Why?
|
Adolescent | 3 | 2022 | 85064 | 0.050 |
Why?
|
Female | 7 | 2022 | 377052 | 0.050 |
Why?
|
Prodrugs | 1 | 2021 | 273 | 0.040 |
Why?
|
Models, Immunological | 1 | 2021 | 535 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 902 | 0.040 |
Why?
|
G1 Phase | 1 | 2020 | 418 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 568 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1097 | 0.040 |
Why?
|
Aminopyridines | 1 | 2022 | 540 | 0.040 |
Why?
|
Serine | 1 | 2022 | 827 | 0.040 |
Why?
|
Synthetic Biology | 1 | 2020 | 187 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 807 | 0.040 |
Why?
|
Nucleotides, Cyclic | 1 | 2018 | 83 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 560 | 0.040 |
Why?
|
Cytoplasm | 1 | 2022 | 1625 | 0.040 |
Why?
|
Benzofurans | 1 | 2018 | 147 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2018 | 195 | 0.040 |
Why?
|
Genome, Human | 1 | 2011 | 4468 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 752 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 968 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 357 | 0.040 |
Why?
|
Gene Expression | 2 | 2022 | 7950 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2017 | 460 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 536 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2018 | 12530 | 0.040 |
Why?
|
Cell Death | 1 | 2022 | 1722 | 0.040 |
Why?
|
Apoproteins | 1 | 2016 | 49 | 0.040 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2020 | 672 | 0.040 |
Why?
|
Oxazoles | 1 | 2017 | 197 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 1000 | 0.040 |
Why?
|
Protein Engineering | 1 | 2020 | 552 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2021 | 867 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2022 | 1681 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2022 | 1923 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1211 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1246 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.030 |
Why?
|
Sulfones | 1 | 2018 | 456 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 614 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2017 | 365 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 975 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1137 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2022 | 1745 | 0.030 |
Why?
|
Amides | 1 | 2017 | 449 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 2010 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1704 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20060 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1902 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3313 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 901 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1230 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2786 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2018 | 996 | 0.030 |
Why?
|
Cell Division | 1 | 2020 | 4694 | 0.030 |
Why?
|
Hepacivirus | 1 | 2019 | 1323 | 0.030 |
Why?
|
Vibrio cholerae | 1 | 2018 | 817 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1836 | 0.030 |
Why?
|
Survivors | 1 | 2021 | 2164 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2022 | 3064 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1580 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3631 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1515 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1698 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1570 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 3393 | 0.020 |
Why?
|
Adult | 2 | 2021 | 212228 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 214618 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2823 | 0.020 |
Why?
|
Hepatitis C | 1 | 2019 | 1521 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 356 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9812 | 0.020 |
Why?
|
Male | 3 | 2021 | 350156 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 40042 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3584 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4089 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5338 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13219 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8561 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4748 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10091 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15899 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 11956 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 24779 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3526 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 4907 | 0.010 |
Why?
|
Infant | 1 | 2021 | 34561 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 41184 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 51355 | 0.010 |
Why?
|
Child | 1 | 2021 | 74418 | 0.010 |
Why?
|
Aged | 1 | 2021 | 162383 | 0.010 |
Why?
|